Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / ALIM - Alimera gets Italian nod for its Iluvien injection to treat a form of eye inflammation

ALIM - Alimera gets Italian nod for its Iluvien injection to treat a form of eye inflammation

Alimera Sciences Inc.

  • Alimera Sciences ( NASDAQ: ALIM ) has got Italian regulatory approval for its Iluvien injection for the treatment of uveitis, a form of eye inflammation.
  • ALIM's Ireland-based European unit, Alimera Sciences Europe, got an approval and was granted pricing and reimbursement for Iluvien by the Italian Medicines Agency (AIFA), Alimera said in a statement on Friday.
  • The indication was for the prevention of relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye.
  • ALIM said it would launch Iluvien through its Italian distribution partner, ophthalmic company SIFI.
  • It did not disclose the pricing determination for Iluvien.
  • ALIM stock closed marginally higher at $5.32 on Thursday.

For further details see:

Alimera gets Italian nod for its Iluvien injection to treat a form of eye inflammation
Stock Information
Company Name: Alimera Sciences Inc.
Stock Symbol: ALIM
Market: NASDAQ
Website: alimerasciences.com
Menu
ALIM ALIM Quote ALIM Short ALIM News ALIM Articles ALIM Message Board
Get ALIM Alerts

News, Short Squeeze, Breakout and More Instantly...